Hut 8 Corp vs IQVIA Holdings Inc. Common Stock — how do they compare? Hut 8 Corp trades at $84.13 (market cap $9.82B), while IQVIA Holdings Inc. Common Stock trades at $259.97 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 4.3× Hut 8 Corp's market cap, and IQVIA Holdings Inc. Common Stock is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hut 8 Corp for 11 Days and IQVIA Holdings Inc. Common Stock for 1 Days on average.
| HUT | IQV | |
|---|---|---|
Market Cap | $9.82B | $42.61B |
Volume | 10,272,678 | 988,398 |
Sector | Financials | Health |
52-Week High | $133.02 | $275.02 |
52-Week Low | $33.76 | $156.66 |
Typical Hold Time | 11 Days | 1 Days |
Enterprise Value | $17.25B | $56.77B |
Signals from Pluang's Aura AI — not financial advice
HUT trades at $84.27, down 5.63% today, with a bearish technical outlook despite oversold RSI readings. The company reported negative earnings in recent quarters, missing expectations, with a net income margin of -188.59% for 2026. Recent positive developments include securing a $1.07 billion credit facility and analyst optimism around AI infrastructure contracts.
While analyst consensus is strongly bullish with a $162.69 price target, significant execution risks persist given negative profitability and cash flow challenges. The stock offers high potential upside if AI infrastructure contracts materialize but carries substantial risk from ongoing losses and competitive pressures in the digital infrastructure space.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →